patient weight Applications
-
Potential breakthrough treatment option for Critical Limb Ischemia (CLI)
Our First DCGI Approved Stem Cell Product: Stempeucel® is the FIRST innovative stem cell based biological product to be approved by DCGI (Indian FDA) for manufacturing and marketing for the treatment of Critical Limb Ischemia (CLI). Stempeucel® product has been licensed to Cipla in India. Stempeutics is seeking partnership for further clinical development and commercialization of Stempeucel® for Global ...
By Stempeutics Research Pvt. Ltd. based in Bangalore, INDIA.
-
Body Composition Analysis
Empower your patients to change habits and take charge of their health. Go beyond the ...
By ImpediMed Inc. based in Carlsbad, CALIFORNIA (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you